Explore the latest in heart failure, including recent guidelines and advances in treatment of HF with reduced and preserved ejection fraction.
This cohort study assesses the prevalence of preexisting heart failure in older patients with diffuse large B-cell lymphoma and its association with treatment patterns and outcomes using data from the Surveillance, Epidemiology, and End Results–Medicare registry.
This randomized crossover trial assessed if implanting and programming a pacemaker for rate-adaptive atrial pacing improved exercise performance in patients with heart failure with preserved ejection fraction and chronotropic incompetence at a single US tertiary referral center.
This review discusses current evidence regarding the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of heart failure with preserved ejection fraction.
This randomized clinical trial evaluates the efficacy of sacubitril/valsartan vs valsartan in the treatment of left ventricular diastolic function in patients with pre–heart failure with preserved ejection fraction.
This economic evaluation investigates if the addition of a sodium-glucose cotransporter-2 inhibitor to standard therapy would be cost-effective in individuals with heart failure and preserved ejection fraction.
This cohort study assesses the association between change in N-terminal pro–B-type natriuretic peptide with risk for incident heart failure and death.
This cohort study analyzes data for participants from the Southern Community Cohort Study to determine whether rurality is associated with increased risk of heart failure and whether rurality-associated risk varies by race and sex.
This cross-sectional study estimates out-of-pocket costs of heart failure with reduced ejection fraction medication regimens in Medicare Part D under current law and the Inflation Reduction Act.
This randomized clinical trial assesses the effects of a moderately accelerated personalized backup heart rate compared with 60 bpm in patients with heart failure with preserved ejection fraction (HFpEF) who have preexisting pacemaker systems that limit pacemaker-mediated dyssynchrony.
This study attempts to incidence of percent of days alive out of hospital before and after left ventricular assist device implantation and explores its association with established quality metrics.
This post hoc analysis of 2 randomized clinical trials analyzes data for patients with heart failure and with and without gout to gauge the effects of dapagliflozin on the risk of clinical outcomes and the new use of uric acid–lowering agents and colchicine.
This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.
This case report describes a diagnosis of Paget-Schroetter syndrome in a man in his 50s with a network of small veins in the left infraclavicular region discovered after unsuccessful left subclavian vein puncture.
Customize your JAMA Network experience by selecting one or more topics from the list below.